论文部分内容阅读
进展期贲门癌的治疗以手术为首选方法,治疗效果较差.即使施行根治术也往往不能达到根治效果,大多数患者死于腹腔复发和转移.常见的复发转移部位是手术野区域、淋巴结、腹膜表面及盆腔脏器.临床上常用的辅助治疗方法如静脉化疗、腹腔内化疗药物、蒸馏水浸泡等效果并不理想.近年来,用内源放射性物质诊断、治疗肿瘤的报道日趋增多.朱瑞森等用~(131)I-MIBC 对58例恶性嗜铬细胞瘤临床治疗的疗效副反应进行探讨,匡安仁等对放射性碘对于肝癌的趋瘤性进行了研究,孙爱君等对~(18)F-FDG PET 头颈部癌治疗后复发中的应用进行了研究,兰青等用~(35)S 标记 SZ39导向治疗胶质瘤、李广宙 et al 用~(32)p 胶体瘤内注射结合肝动脉化疗栓塞治疗巨块
The treatment of advanced cardiac cancer is the first choice for surgery, and the treatment effect is poor. Even if radical surgery is performed, it often fails to achieve a radical effect. Most patients die of recurrence and metastasis in the abdominal cavity. The common recurrence and metastasis site is the surgical field, lymph nodes, Peritoneal surface and pelvic organs. Clinically used auxiliary treatment methods such as intravenous chemotherapy, intraperitoneal chemotherapy drugs, distilled water immersion and other effects are not satisfactory. In recent years, reports of endogenous radioactive substances for diagnosis and treatment of tumors have been increasingly increased. Zhu Ruisen et al. Clinical side effects of clinical treatment of 58 cases of malignant pheochromocytoma were explored with ~(131)I-MIBC. Wei Anren et al. studied the tumorigenicity of hepatoma with radioactive iodine. Sun Aijun et al. ~(18)F- The use of FDG PET for recurrence after treatment of head and neck cancer was studied. Lan Qing et al. used the ~(35)S marker for SZ39-guided treatment of glioma, Li Guangzhou et al used ~(32)p colloid intratumoral injection combined with hepatic arterial chemotherapy. Embolization treatment block